Stemcell Holdings, Inc. Stock Other OTC
Equities
STMM
US85858N2027
Pharmaceuticals
Sales 2016 | 3.34M 4.58M | Sales 2017 | 6.18M 8.47M | Capitalization | 1.64M 2.25M |
---|---|---|---|---|---|
Net income 2016 | 1M 1.37M | Net income 2017 | 2M 2.74M | EV / Sales 2016 * | - |
Net cash position 2016 * | - 0 | Net cash position 2017 * | - 0 | EV / Sales 2017 * | - |
P/E ratio 2016 * |
-
| P/E ratio 2017 * |
-
| Employees | - |
Yield 2016 * |
-
| Yield 2017 * |
-
| Free-Float | 99% |
1st Jan change | Capi. | |
---|---|---|
-1.62% | 89.22B | |
+1.32% | 40.49B | |
-15.62% | 32.79B | |
+64.13% | 26.23B | |
-22.04% | 14.52B | |
-7.66% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |